Skip to main content

Apparent self-tolerance of commensal-specific B cells and their responses to infection

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-07-17

About This Grant

Project summary/abstract: How the immune system maintains a balance between containing the intestinal microbiota and limiting inflammation is an important field of study with relevance to numerous human diseases. The immune system must also balance the need for having a diverse B cell receptor (BCR) repertoire with maintaining self-tolerance. Tolerance of self-reactive B cells is enforced during B cell maturation in the bone marrow (BM) and peripherally through B cell anergy, which limits their lifespan and makes them hyporeactive. Commensal microbes add complexity to the idea of tolerance, as they are an important source of foreign antigen, but are not necessarily harmful. It is rarely considered whether the continuous presence of commensal-derived antigen could have tolerogenic effects on B cells. This proposal describes a new model where we find that a microbial antigen specifically tolerizes B cells, and will test the ability of the tolerized microbial antigen-specific B cells to respond to commensal antigen or infection. We have generated three BCR-knock-in (KI) mouse strains expressing lipopolysaccharide (LPS)-specific BCRs of either low- or high- affinity heavy chains, or a high-affinity light chain, collectively referred to as 33a KIs. These BCRs were derived from an expanded B cell clone that was responding to infection with Salmonella, but also binds a portion of small-intestinal commensal microbes. 33a KI B cells show hallmarks of self-tolerance mechanisms including clonal deletion, receptor editing, and anergy. Critically, transferring BM from SPF mice into lethally irradiated germ-free mice improved B cell development, demonstrating microbially derived antigen can contribute to B cell tolerance. Strict B cell tolerance could generate immunological blind spots for certain microbial antigens, while conversely a lack of tolerance could cause overwhelming inflammation at barrier sites. Intriguingly, we observe that 33a KI B cells form germinal centers in the Peyer’s patches (PPs) at steady-state, and a robust splenic extrafollicular response to systemic Salmonella infection, demonstrating that despite tolerization, the B cells can respond in certain contexts. The central goal of this proposal is to define the fundamental properties of this novel type of B cell response during homeostasis and following infection. In Aim 1 we will determine whether 33a B cells undergo classical germinal center responses in the PP during homeostasis, including the formation of long-lived memory B cells and plasma cells. In Aim 2, we will define the 33a B cell response to infection, and test whether the nature of antigenic stimulation impacts their response using oral infection with mutant Salmonella strains and a closely related pathogen, Yersinia pseudotuberculosis. This project tests a new conceptual framework that microbial antigen can contribute to both B cell tolerance and inflammation as needed, which will in turn have important implications for understanding many human disease conditions. The knowledge and skills I will attain from the proposed work will be broadly applicable and help me achieve my overall goal of becoming an independent investigator studying the immune balance of tolerance and protection.

Grant Summary

Apparent self-tolerance of commensal-specific B cells and their responses to infection is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $50K for university, nonprofit, healthcare org. Applications are due 2029-04-30 (open). Check eligibility and apply with FindGrants.

Not quite the right fit?

Search 9,000+ open grants, or get matches ranked for your organization — free.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $50K

Deadline

2029-04-30

Complexity
Medium
  1. 1Confirm your organization is eligible for Apparent self-tolerance of commensal-specific B cells and their responses to infection from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Apparent self-tolerance of commensal-specific B cells and their responses to infection: Frequently Asked Questions

Who is eligible for the Apparent self-tolerance of commensal-specific B cells and their responses to infection?

Apparent self-tolerance of commensal-specific B cells and their responses to infection is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Apparent self-tolerance of commensal-specific B cells and their responses to infection provide?

Apparent self-tolerance of commensal-specific B cells and their responses to infection provides up to $50K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Apparent self-tolerance of commensal-specific B cells and their responses to infection deadline?

Applications for Apparent self-tolerance of commensal-specific B cells and their responses to infection are due 2029-04-30 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Apparent self-tolerance of commensal-specific B cells and their responses to infection?

To apply for Apparent self-tolerance of commensal-specific B cells and their responses to infection, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.